Success Metrics

Active Trials

2(29%)

Phase Distribution

Ph phase_2

57%

Ph phase_3

14%

Ph phase_1

29%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 1Safety & dosage

2(28.6%)

Phase 2Efficacy & side effects

4(57.1%)

Phase 3Large-scale testing

1(14.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Other(4)

Detailed Status

unknown4

Recruiting2

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

N/A

Most Advanced

Phase 3

Trials by Phase

Phase 12 (28.6%)

Phase 24 (57.1%)

Phase 31 (14.3%)

Trials by Status

unknown457%

not_yet_recruiting114%

recruiting229%

Recent Activity

2 active trials

Showing 5 of 7

recruitingphase_2

Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors

NCT06947291

recruitingphase_3

A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer

NCT06296706

not_yet_recruitingphase_1

A Study of Docetaxel for Injection (Albumin-bound) and SG001 in Combination With Cisplatin and Simultaneous Radiotherapy for Locally Advanced Unresectable Esophageal Squamous Carcinoma.

NCT06136988

unknownphase_2

A Study of Docetaxel for Injection (Albumin-bound) in Patients With Pancreatic Cancer

NCT05616494

unknownphase_2

A Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer

NCT05705635

View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT06947291Phase 2

Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors

Recruiting

NCT06296706Phase 3

A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer

Recruiting

NCT06136988Phase 1

A Study of Docetaxel for Injection (Albumin-bound) and SG001 in Combination With Cisplatin and Simultaneous Radiotherapy for Locally Advanced Unresectable Esophageal Squamous Carcinoma.

Not Yet Recruiting

NCT05616494Phase 2

A Study of Docetaxel for Injection (Albumin-bound) in Patients With Pancreatic Cancer

Unknown

NCT05705635Phase 2

A Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer

Unknown

NCT05325229Phase 2

A Study of Docetaxel for Injection (Albumin-bound) in Combination With Bevacizumab in Patients With Ovarian Cancer

Unknown

NCT04811118Phase 1

The Comparison of the Pharmacokinetics of Albumin-bound Docetaxel and Taxotere